2014

Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes

Four-month study detailing effects of treatment of HIV-positive

individuals with American Biotech Labs (ABL) ASAP 10 treatment indicates

significant improvement in the condition of the subjects after treatment;

in-vitro laboratory work shows that ABL nanosilver particles can block

entry of the virus into cells, "eventually destroying the virus"

    ALPINE, UT, Aug. 29 /PRNewswire-FirstCall/ - American Biotech Labs,
 developer of a new class of products based on the company's patented
 nano-catalytic SilverSol Technology(TM), today announced that a preliminary
 study of the effect of the company's ASAP 10 treatment on HIV-positive
 individuals has been published in the first issue of the Journal of the
 Science of Healing Outcomes (JSHO; www.thejsho.com/pdf/Effect.pdf). JSHO is
 a scholarly health journal that publishes compelling new medical research
 data and reports.
 
     The study was conducted over four months with seven HIV-positive
 patients, each of whom was administered 15 ml of ABL ASAP 10 ppm (parts per
 million) four times daily. As a result of the ABL treatment, "Clinically,
 (the patients) were 100 percent fit and were feeling much better after the
 treatment period," said Dr. B.M. Hegde, world-renowned cardiologist and
 editor of JSHO.
 
     During the course of the therapy, the patients experienced an average
 body weight gain of eight kilograms (17.6 pounds) and an average
 T-lymphocyte count increase of 180 per micro-liter (39.52 percent).
 
     One of the study's most significant findings, said Hegde, was the
 effect of ABL ASAP on HIV, the AIDS-causing virus. "Our recent laboratory
 work of the effect of nano silver in vitro on the... virus did show that
 the nanosilver particles could bind to (HIV) and could potentially block
 the viral entry into cells, eventually destroying the virus."
 
     Hegde added, "Now that we have the laboratory results of the drug's
 efficacy and safety, we are planning a large scale controlled study of the
 application to HIV positive individuals in the near future."
 
     About American Biotech Labs
 
     American Biotech Labs (ABL; www.AmericanBiotechLabs.com), founded in
 1998, utilizes patented processes and SilverSol Technology(TM) to create
 singularly powerful and effective nano-catalytic silver products. In
 extensive testing performed by a variety of respected laboratories and
 researchers, ABL's silver hydrosol has consistently demonstrated the
 ability, without any known toxic side effects, to destroy a wide range of
 bacteria, viruses, yeast, and molds. ABL products have been approved by the
 U.S. EPA as a disinfectant for dental water lines, and as a surface
 disinfectant for bacteria, yeast and mold in hospital, residential,
 commercial and industrial settings. The company's products are sold
 worldwide at health food stores and by medical professionals under the
 Silver Biotics(R) and ASAP Solution(R) brands and through a variety of
 private labels.
 
 
 

SOURCE Clifton Mining Company

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.